Dewey Kathryn G, Oaks Brietta M
Program in International and Community Nutrition and Department of Nutrition, University of California, Davis, CA
Program in International and Community Nutrition and Department of Nutrition, University of California, Davis, CA.
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1694S-1702S. doi: 10.3945/ajcn.117.156075. Epub 2017 Oct 25.
Both iron deficiency (ID) and excess can lead to impaired health status. There is substantial evidence of a U-shaped curve between the risk of adverse birth outcomes and maternal hemoglobin concentrations during pregnancy; however, it is unclear whether those relations are attributable to conditions of low and high iron status or to other mechanisms. We summarized current evidence from human studies regarding the association between birth outcomes and maternal hemoglobin concentrations or iron status. We also reviewed effects of iron supplementation on birth outcomes among women at low risk of ID and the potential mechanisms for adverse effects of high iron status during pregnancy. Overall, we confirmed a U-shaped curve for the risk of adverse birth outcomes with maternal hemoglobin concentrations, but the relations differ by trimester. For low hemoglobin concentrations, the link with adverse outcomes is more evident when hemoglobin concentrations are measured in early pregnancy. These relations generally became weaker or nonexistent when hemoglobin concentrations are measured in the second or third trimesters. Associations between high hemoglobin concentration and adverse birth outcomes are evident in all 3 trimesters but evidence is mixed. There is less evidence for the associations between maternal iron status and adverse birth outcomes. Most studies used serum ferritin (SF) concentrations as the indicator of iron status, which makes the interpretation of results challenging because SF concentrations increase in response to inflammation or infection. The effect of iron supplementation during pregnancy may depend on initial iron status. There are several mechanisms through which high iron status during pregnancy may have adverse effects on birth outcomes, including oxidative stress, increased blood viscosity, and impaired systemic response to inflammation and infection. Research is needed to understand the biological processes that underlie the U-shaped curves seen in observational studies. Reevaluation of cutoffs for hemoglobin concentrations and indicators of iron status during pregnancy is also needed.
缺铁(ID)和铁过量均可导致健康状况受损。有大量证据表明,孕期不良出生结局风险与母体血红蛋白浓度之间呈U型曲线关系;然而,尚不清楚这些关系是归因于铁状态低和高的情况,还是其他机制。我们总结了来自人体研究的关于出生结局与母体血红蛋白浓度或铁状态之间关联的现有证据。我们还回顾了铁补充剂对ID低风险女性出生结局的影响,以及孕期高铁状态产生不良影响的潜在机制。总体而言,我们证实了母体血红蛋白浓度与不良出生结局风险呈U型曲线,但这种关系在不同孕期有所不同。对于低血红蛋白浓度,当在孕早期测量血红蛋白浓度时,与不良结局的关联更为明显。当在孕中期或孕晚期测量血红蛋白浓度时,这些关系通常会变弱或不存在。高血红蛋白浓度与不良出生结局之间的关联在所有三个孕期均很明显,但证据不一。关于母体铁状态与不良出生结局之间关联的证据较少。大多数研究使用血清铁蛋白(SF)浓度作为铁状态指标,这使得结果的解释具有挑战性,因为SF浓度会因炎症或感染而升高。孕期补充铁的效果可能取决于初始铁状态。孕期高铁状态可能通过多种机制对出生结局产生不良影响,包括氧化应激、血液粘度增加以及对炎症和感染的全身反应受损。需要开展研究以了解观察性研究中所见U型曲线背后的生物学过程。还需要重新评估孕期血红蛋白浓度的临界值和铁状态指标。